Thuja Capital

Summary

In 2006 was created Thuja Capital, which is appeared as VC. The leading representative office of defined VC is situated in the Utrecht. The venture was found in Europe in The Netherlands.

The common things for fund are deals in the range of 5 - 10 millions dollars. The top amount of exits for fund were in 2018. The fund is constantly included in 2-6 investment rounds annually. The top activity for fund was in 2007. Despite it in 2019 the fund had an activity. Opposing the other organizations, this Thuja Capital works on 6 percentage points more the average amount of lead investments. The real fund results show that this VC is 55 percentage points more often commits exit comparing to other companies.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Thuja Capital, startups are often financed by AlpInvest Partners, Oxford Bioscience Partners, Global Life Science Ventures. The meaningful sponsors for the fund in investment in the same round are BOM Capital, Health Innovation Fund, DSM Venturing. In the next rounds fund is usually obtained by Van Herk Ventures, EASME - EU Executive Agency for SMEs, BOM Capital.

The current fund was established by Harrold van Barlingen. Besides them, we counted 2 critical employees of this fund in our database.

The fund has exact preference in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Health Care, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight Curacyte AG, Drug Abuse Sciences, Salvia BioElectronics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - The Netherlands. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.